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Polymeric near-infrared absorbing dendritic
nanogels for eﬃcient in vivo photothermal
cancer therapy†
Maria Molina, Stefanie Wedepohl and Marcelo Calderón*
In recent years, several near-infrared light absorbing inorganic
nanomaterials have been developed for photothermal therapy.
However, their biological fate after injection limits their clinical
utilization. In this work, we developed a novel polymeric near-
infrared light absorbing material based on a biocompatible ther-
moresponsive nanogel that is semi-interpenetrated with polyani-
line, a conjugated polymer with strong near-infrared absorbance.
This polymeric nanocomposite generates heat after being irra-
diated by NIR light, thereby inducing a local hyperthermia that is
used for photothermal cancer therapy in vitro and in vivo.
Introduction
Photothermal therapy (PTT) has emerged as promising anti-
cancer therapy due to its high specificity and eﬃcacy. PTT is
based on the conversion of light into heat to generate a mild
or severe local hyperthermia which leads to diﬀerent results
like cell sensitization or ablation, enhanced tissue penetration
by temperature-induced increase in the tissue pore size, and
drug triggered release.1 Near-infrared (NIR) light has the key
advantage of being minimally absorbed by skin and tissues.
Within the NIR window, which comprises wavelengths of
about 650 to 900 nm, light can penetrate tissue in the order of
hundreds of micrometers to centimeters. In the last decade,
diﬀerent inorganic materials with photothermal properties
have been used successfully in anticancer therapy.2 Photo-
active materials such as carbon nanotubes,3 magnetic nano-
materials,4 or gold nanoparticles,5 activated with NIR
radiation, were shown to be eﬀective in the hyperthermic treat-
ment of diﬀerent cancers.6 However, there are still some issues
related to biocompatibility and biodegradability of those in-
organic nanomaterials that limit their applicability.7 As an
approach to solve this problem, conjugated polymers have
been studied as photothermal agents in the last few years. NIR
absorbing, conjugated polymers show excellent photostability,
good biocompatibility, and high photothermal conversion.8–10
Because their major drawback is the low solubility in water,
diﬀerent strategies have been followed to increase their solubi-
lity, whereby stabilization of the conjugated polymeric nano-
particles with water-soluble polymers has been the most
studied one.11 Until now, semi-interpenetration (sIPN) within
hydrophilic nanosized networks has not been considered.
In order to create well-defined, monodisperse, and stable
nanostructures on the molecular level, highly branched den-
dritic polymers have been successfully employed over the last
couple of decades. There has been much interest in the fabri-
cation of dendritic nanogels (NGs), which are high molecular
weight crosslinked polymers that combine the characteristics
of dendritic polymers with crosslinked macroscopic gels to
yield soluble particles with a useful size range between 20 and
200 nm.12 Temperature-sensitive NG systems are versatile in
design, their phase transition temperatures can be tuned, and
they feature passive targeting ability.13 By combining thermo-
responsive polymers with dendritic polyglycerol (dPG), our
group has developed a series of dendritic thermoresponsive
NGs that are suitable for biomedical applications.14–16 The
presence of dPG as a macro-crosslinker, attached via a bio-
degradable ester linkage, provides high biocompatibility and
hydrophilicity and, more importantly, can avoid the precipi-
tation of the NGs in the collapse state above the transition
temperature (Tp). In an eﬀort to further control the existing
temperature-responsive systems, current studies have com-
bined temperature with other stimuli such as pH and light.17
NIR absorbers have been combined with thermoresponsive
gels in order to use NIR light as an external trigger for struc-
tural changes in thermoresponsive materials.18,19
Herein, we have synthesized a thermoresponsive poly(N-iso-
propylacrylamide) (PNIPAM) based NG crosslinked with dPG
and semi-interpenetrated with polyaniline (PANI) which gener-
ates heat after being irradiated by NIR light, thereby inducing
a local hyperthermia (Fig. 1) for its use in PTT. At the body
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temperature, the shape of the dendritic NG changes because
of its thermoresponsive properties, which triggers its shrink-
age, but, due to the presence of dPG, the collapsed NG still
has good suspension and does not precipitate. In this hydro-
phobic state, as observed in previous reports, the collapsed
NGs can be expected to more easily accumulate in cells and/or
penetrate tissues.20
Results and discussion
NGs based on PNIPAM crosslinked with 33 wt% of dPG
(PNIPAM-dPG) were synthesized following the procedure pre-
viously reported by our group.14 In a further step, PNIPAM-
dPG/PANI NGs were synthesized following a two-step semi-
interpenetration procedure. Briefly, dry NGs were swollen in a
solution of aniline and polymerization was started in situ by
the addition of ammonium persulfate. To establish the con-
ditions for the in situ polymerization of PANI inside the NGs to
form a nanocomposite, diﬀerent reaction conditions were
screened (Table 1).
At low concentrations of aniline (0.05 M) or short polymeri-
zation times (7 min), oligomers of aniline were obtained.
When a high concentration of aniline was used, the PANI
started to precipitate out of the solution. Using 0.1 M of
aniline and 30 min of polymerization time, a stable PANI dis-
persion with a reproducible size and thermoresponsive pro-
perties was obtained (PNIPAM-dPG/PANI).
The in situ polymerization of aniline was confirmed by
1H-NMR, FTIR, and UV-Vis measurements (ESI†). After the
semi-interpenetration of the NIR absorbing polymer into the
NGs, two new bands corresponding to the PANI appeared in
the FTIR spectrum with the CvC stretching at 1590 cm−1 and
the C–N stretching absorption band at 1310 cm−1, while all the
absorption bands of the PNIPAM and dPG remained the
same.14 Moreover, the 1H-NMR spectrum confirmed the pres-
ence of PANI in the composite with a peak at ∼7.4 ppm corres-
ponding to the aromatic protons. On the other hand, after the
in situ polymerization of aniline inside the NG, a typical UV-
Vis spectrum of PANI was observed. The spectra changed with
the pH in accordance with those previously reported for PANI
films in the emeraldine state.21 This result indicates that the
PANI chains inserted into the NG were unaltered and respon-
sive to changes in the solution environment.
Atomic force microscopy (AFM) and cryogenic transmission
electronic microscopy (cryoTEM) showed spherical individual
nanoparticles and some aggregates. In the AFM micrographs
(Fig. 2A) we observed that the NGs appear like core–shell
structures. This could be explained by the synthetic procedure
in agreement with the results shown by Zhang et al.22 At the
beginning of the reaction, due to the interaction of aniline
Fig. 1 Schematic representation of the synthesis of a semi-interpenetrating NIR-thermosensitive NG and its application in PTT.
Table 1 Reaction conditions for sIPN NG synthesis
NG (mg mL−1) Aniline (M)
Polymerization
time (min) Results
10 0.05 30 Oligomers
10 0.1 30 PANI dispersion
10 0.1 7 Not reproducible
10 0.5 30 PANI precipitate
Fig. 2 Characterization of PNIPAM-dPG/PANI NGs. (a) AFM, (b) cryoTEM, and (c) hydrodynamic diameter (Dh) vs. temperature (T ) as measured by DLS.
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with PNIPAM, the concentration of aniline inside the NG was
much higher and the polymerization started inside the
network. After that, the reaction mainly took place on the
surface of the NG. Thus, the particles underwent structural
changes from PNIPAM-dPG to sIPN and finally to the sIPN–
PANI core–shell throughout the reaction.
Dynamic light scattering (DLS) measurements revealed an
increment of 100 nm in the size of the bare NGs after the
semi-interpenetration, while the Tp remained the same
(∼34 °C) (Fig. 2C). Above the Tp, the size of the composites
decreased from 220 nm to 150 nm. To further prove the
colloidal stability of the NGs above the Tp, nanoparticle tracking
analysis (NTA) was performed, which made it possible to count
the particles at diﬀerent temperatures. In the case of the PNIPAM-
dPG/PANI NGs, the concentration of the particles was constant,
∼1.2 × 109 particles per mL at 25 and 42 °C, which demonstrated
that the NGs had neither aggregated nor precipitated. Moreover
the amount of the incorporated PANI was studied by UV-Vis and
was found to be 0.9 mg of PANI per mg of PNIPAM-dPG.
As the material was supposed to be applied in PTT, we
studied the increase in the temperature of the nanocomposites
under NIR irradiation. Fig. 3 shows how the increase in tem-
perature depended on the concentration of the nanocomposite
and irradiation time. When only water was irradiated, the
temperature increased by a maximum of 3 °C while with
20 μg mL−1 of nanocomposites, the temperature increased by
8 °C after 10 min of irradiation, which is enough for mild
hyperthermia conditions.23
After studying the outstanding physicochemical properties
of the sIPN NGs, further biological characterization was per-
formed in order to use these systems in vivo. The cytotoxicity
of PNIPAM and PNIPAM-dPG/PANI on A2780 human ovarian
carcinoma cells was determined by the MTT assay. The A2780
cells that had been incubated for 48 hours with PNIPAM-dPG
or PNIPAM-dPG/PANI showed no reduction in viability up to
0.1 mg mL−1 and relative viabilities over 50% at a concen-
tration of 1 mg mL−1 (Fig. 4a). The uptake of PNIPAM-dPG/
PANI into cells was indirectly monitored by determining the
concentration in the cell culture supernatant (Fig. 4b). After
64 h, the concentration was about 30 µg mL−1 less than that
initially incubated. In addition, we observed that the cells were
dark colored after trypsinization and washing with phosphate
buﬀered saline (PBS) or media (Fig. 4c). The color remained
after repeated trypsinization, reculturing, and washing which
confirmed that the compound was located inside the cells.
For the study of the photothermal eﬀect in vitro, the cells
were released from the cell culture flask, washed, and centri-
fuged into PCR tubes that allowed a rapid transmission of heat
through the walls of the tubes. After removing most of the
media, the pellet of 1 million cells had about the volume of a
Fig. 4 (a) Cytotoxicity of PNIPAM and PNIPAM-dPG/PANI on A2780
cells as determined by the MTT assay. (b) PNIPAM-dPG/PANI concen-
tration in culture medium of A2780 cells as determined by absorbance
measurements over time. (c) Color of the cell pellet after incubation
with PNIPAM-dPG/PANI (right) compared to untreated cells (left).
Fig. 5 Relative viabilities of A2780 cells treated with PNIPAM-dPG/PANI
or untreated, irradiated with NIR laser or heated to 42 °C (“Temp.”).
Fig. 3 Change in temperature vs. time of irradiation for dispersions of
PNIPAM-dPG/PANI at diﬀerent concentrations. Thermographic images
on the left and right show the well in which the test with a solution of
80 μg mL−1 of PNIPAM-dPG/PANI was performed (scale on the right:
false color code).
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5 µL drop, which resembled a small tumor tissue. This cluster
was irradiated with a NIR laser (785 nm) under constant moni-
toring with a thermal camera to ensure that the temperature
did not exceed 42 °C ± 1 °C. As control for the eﬀect of
hyperthermia alone, parallel samples were incubated in a water
bath at 42 °C. Irradiation or heating was performed either one
time for 5 min or four times for 5 min each with the PNIPAM-
dPG/PANI incubated cells as well as untreated cells. The viabil-
ities were measured by the MTT assay 24 h after re-seeding the
treated cells into 96-well plates (Fig. 5). The A2780 cells which
had taken up PNIPAM-dPG/PANI irradiated with a NIR laser
showed a markedly reduced viability after a single treatment for
5 min, compared to 80% of the untreated control cells that had
been irradiated for the same time. Moreover, 4 irradiation
cycles resulted in a complete loss of the cell viability, whereas
the control cells again were not compromised. The eﬀect of
hyperthermia for 5 min alone was not diﬀerent from the con-
trols; we only saw a decrease in viability to about 60% when the
hyperthermia was repeated 4 times. As a control for the stress
from centrifuging and standing as a cell cluster for a prolonged
period of time outside of the incubator, another cell sample
was treated under the same conditions but neither heated nor
irradiated. The viability of these control cells was not markedly
aﬀected and was comparable to the untreated cells in the other
series (Fig. 5, columns labeled “no heat”). This result demon-
strated the eﬃcacy of the focus heat generation compared to
the whole-body hyperthermia.
This promising result encouraged us to further use these
systems for localized hyperthermia therapy. Therefore the
in vivo tolerability of the PNIPAM-dPG/PANI NGs was studied
in female nude (NMRI, nu/nu) mice in a two-step protocol.
The mice were first treated with a single injection of increasing
doses of PNIPAM-dPG/PANI from 10 to 100 mg kg−1 and the
body weight was measured for a period of 3 weeks. The results
showed that the mice tolerated up to 100 mg kg−1 without any
significant signs of toxicity or drug related body weight loss
when given intravenously as a single dose (ESI†). Next, 3 mice
were treated with the maximum injected dose, 100 mg kg−1
once per day during 5 consecutive days. The mice were
observed for a follow-up period of 18 days. The treatment
resulted in blue-stained ear ends and tails, but the color washed
out within two days. No significant toxic eﬀects were observed
during this period (accumulated dose: 500 mg kg−1) (ESI†).
Once the high in vivo tolerability of this encouraging
material was proved, we proceeded to study the therapeutic
eﬀect in vivo. A2780 tumor transplants were obtained from
tumors, cut into small pieces and transplanted subcutaneously
into female nude mice (Taconic). The mean tumor volume at
this time was 0.086–0.088 cm3. The mice were injected intra-
tumorally or intravenously with a single dose of 10 or
100 mg kg−1 of PNIPAM-dPG/PANI, respectively, or PBS and
PNIPAM-dPG as controls. At the indicated time points, the
mice were narcotized and the tumors were exposed to NIR
laser light at a distance of about 5 cm for 5 min at a maximum
radiation power of 500 mW. The tumor volume and body
weight were then monitored two to three times a week until
day 39. Fig. 6 summarizes the tumor volume change [treated
to control (T/C)] resulting from the diﬀerent treatments.
There was no or only a weak inhibitory eﬀect of the NGs
without NIR irradiation as well as with the control PNIPAM-
dPG with irradiation. In contrast, intratumoral injection of
PNIPAM-dPG/PANI followed by NIR treatment resulted in a
tumor growth inhibition by 55.3%. When injected intra-
venously, the therapeutic eﬀect was expected to depend on the
successful accumulation of the particles in the tumor region in
suﬃcient concentrations. The NGs were injected intravenously
and the tumor was irradiated after 6, 24, or 48 h. When NIR
treatment was done after 6 h, tumor growth inhibition was
about 30%, and after 48 h, only ∼8%. Tumor growth inhibition
was optimal when irradiating 24 h after intravenous injection,
resulting in a tumor growth inhibition of ∼52.2%, which was
nearly as eﬀective as intratumoral injection. Our results indi-
cated that the passive accumulation of the NGs in the tumor
was suﬃciently concentrated to allow a successful treatment.
Conclusions
In summary, we have formulated NIR light sensitive organic
nanoparticles based on PNIPAM-dPG/PANI as a novel photo-
Fig. 6 (a) Thermographic image of a mouse injected with PNIPAM-dPG/PANI after 10 min irradiation and (b) tumor volume change [treated to
control (T/C)] (%) of tumors in female nude mice treated at day 14 after transplantation with PBS, PNIPAM-dPG, PNIPAM-dPG/PANI, with and
without irradiation.
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thermal agent and used for highly eﬀective in vivo hyperther-
mia treatment of cancer cells. By semi-interpenetrating conju-
gated polymers in thermoresponsive polymeric NGs, a
nanocomposite was obtained with excellent compatibility in
physiological environments. This platform provides an oppor-
tunity to load the NG with anticancer drugs as well as to attach
targeting moieties to the dPG. Thus, these nanoparticles
appear promising for cancer therapy. Moreover, the studies in
vivo showed that the mice tolerated up to 100 mg kg−1 of
PNIPAM-dPG/PANI, given at 5 consecutive days (accumulated
dose: 500 mg kg−1) without any significant sign of toxicity. Fur-
thermore, the therapeutic eﬀect study indicated that the com-
bination of systemic treatment with PNIPAM-dPG/PANI and
NIR exposure resulted in a higher sensitivity of the tumors
compared to the controls alone or with NIR. Based on the sim-
plicity and the low cost of synthesis together with the low cyto-
toxicity, high tolerability, and promising therapeutic eﬀect in
vivo, PNIPAM-dPG/PANI has been shown to be an excellent
candidate for further studies. This work shows the first
approach to use PNIPAM-dPG/PANI in PTT; additional strat-
egies to enhance targeting and synergetic PTT combined with
chemotherapy are currently being investigated by our group.
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